MLSC Neuroscience Consortium
Invests in preclinical neuroscience teams at Massachusetts institutions through the MLSC Neuroscience Consortium to advance neurodegenerative research readiness.
The MLSC Neuroscience Consortium is a co-funded translational research grant program administered by the Massachusetts Life Sciences Center (MLSC) in partnership with eight pharmaceutical and medtech companies: AbbVie, Biogen, Celgene, General Electric, Lundbeck, Merck, Novartis, and Sunovion Pharmaceuticals. Since launching in 2013, the consortium has committed nearly $10 million and supported mo…
Pre-clinical translational neuroscience research at Massachusetts institutions, with particular emphasis on Alzheimer's and neurodegenerative diseases anchored in human disease genetics.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline